USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma

Abstract Glioblastoma (GBM), a World Health Organization (WHO) grade IV glioma, is one of the most lethal brain tumors, with a poor prognosis and limited treatment options. Temozolomide (TMZ), a first-line chemotherapeutic agent, often proves ineffective due to resistance and toxicity associated wit...

Полное описание

Библиографические подробности

Главные авторы:	Jiabing Li, Xiaorong Feng, Zhaohui Liu, Yunfang Deng, Zhiming Sun, Bei Chen, Lihui Wu, Xiaolong Wang, Lin Miao, Liyuan Zeng, Lei Hu, Yuming He, Ying Sheng, Yue Liu, Yu Zhao
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Nature Publishing Group 2025-08-01
Серии:	Cell Death and Disease
Online-ссылка:	https://doi.org/10.1038/s41419-025-07969-3
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!